The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy
Open accessAbstract
Background: The global epidemiology of end-stage kidney disease (ESKD) reflects each nation’s unique genetic, environmental, lifestyle, and sociodemographic characteristics. The response to ESKD, particularly regarding kidney replacement therapy (KRT), depends on local disease burden, culture, and socioeconomics. Here, we explore geographic variation and global trends in ESKD incidence and prevalence and examine variations in KRT modality, practice patterns, and mortality. We conclude with a discussion on disparities in access to KRT and strategies to reduce ESKD global burden and to improve access to treatment in low- and middle-income countries (LMICs). Summary: From 2003 to 2016, incidence rates of treated ESKD were relatively stable in many higher income countries but rose substantially predominantly in East and Southeast Asia. The prevalence of treated ESKD has increased worldwide, likely due to improving ESKD survival, population demographic shifts, higher prevalence of ESKD risk factors, and increasing KRT access in countries with growing economies. Unadjusted 5-year survival of ESKD patients on KRT was 41% in the USA, 48% in Europe, and 60% in Japan. Dialysis is the predominant KRT in most countries, with hemodialysis being the most common modality. Variations in dialysis practice patterns account for some of the differences in survival outcomes globally. Worldwide, there is a greater prevalence of KRT at higher income levels, and the number of people who die prematurely because of lack of KRT access is estimated at up to 3 times higher than the number who receive treatment. Key Messages: Many people worldwide in need of KRT as a life-sustaining treatment do not receive it, mostly in LMICs where health care resources are severely limited. This large treatment gap demands a focus on population-based prevention strategies and development of affordable and cost-effective KRT. Achieving global equity in KRT access will require concerted efforts in advocating effective public policy, health care delivery, workforce capacity, education, research, and support from the government, private sector, nongovernmental, and professional organizations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetes is associated with a high rate of cardiovascular events and is also the leading cause of end-stage renal disease in the Western world (452).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [452]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Diabetes is associated with a high rate of cardiovascular events and is also the leading cause of end-stage renal disease in the Western world (452).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [452]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Closing the gap in a generation: health equity through action on the social determinants of health
Marmot, M. G., Friel, S., Bell, R., Houweling, T. A. J., & Taylor, S. A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61690-6 · Cited by 8,473
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Worldwide access to treatment for end-stage kidney disease: a systematic review
Liyanage, T., Ninomiya, T., Jha, V., Neal, B. C., Patrice, H. M., Okpechi, I. G., Zhao, M., Lv, J., Garg, A. X., Knight, J. F., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61601-9 · Cited by 2,344
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192
Self-citationClinical Practice Guidelines for Vascular Access
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.040 · Cited by 1,596
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
Daugirdas, J. T., Depner, T. A., Inrig, J. K., Mehrotra, R., Rocco, M. V., Suri, R. S., Weiner, D. E., Greer, N. L., Ishani, A., MacDonald, R. H., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.07.015 · Cited by 1,391
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M. A., Bonventre, J. V., Coresh, J., Donner, J., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 961
Goodkin, D. A., Bragg‐Gresham, J. L., Koenig, K. G., Wolfe, R. A., Akiba, T., Andreucci, V. E., Saitō, A., Rayner, H. C., Kurokawa, K., Port, F. K., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100127.54107.57 · Cited by 756
The current and future landscape of dialysis
Himmelfarb, J., Vanholder, R. C., Mehrotra, R., & Tonelli, M. A. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0315-4 · Cited by 727
Flagged first, then by citations
Cited by
Sorted by citations
Chronic kidney disease and the global public health agenda: an international consensus
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00820-6 · Cited by 1,374
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Li, Y., Ning, Y., Shen, B., Shi, Y., Song, N., Fang, Y., & Ding, X. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac218 · Cited by 254
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 164
Wathanavasin, W., Banjongjit, A., Avihingsanon, Y., Praditpornsilpa, K., Tungsanga, K., Eiam‐Ong, S., & Susantitaphong, P. (2022) · Nutrients · doi:10.3390/nu14194077 · Cited by 154
Metadata
- Authors
- Thurlow, J. S., Joshi, M., Yan, G., Norris, K. C., Agodoa, L. Y., Yuan, C. M., & Nee, R.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- University of Virginia (US)
- University of California, Los Angeles (US)
- National Institutes of Health (US)
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2021
- Volume
- 52
- Issue
- 2
- Pages
- 98-107
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- PMC
- PMC8057343
- OpenAlex
- W3139528122
- Semantic Scholar
- 05b07bab0110bf2b0dbec0353ad07b1b281fbf70
- Cited by
- 855
- References
- 84
- Citations by year
- 2026: 141 · 2025: 207 · 2024: 214 · 2023: 170 · 2022: 104 · 2021: 17
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (Z99 DK999999, UL1TR000124, UL1TR001881)
- National Institute on Aging (P30AG021684)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK112008)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- end-stage renal disease, renal replacement therapy, dialysis, hemodialysis, regional variation, incidence and prevalence, survival, treatment gap, health care access, low- and middle-income countries, health disparities, global equity, health policy
- MeSH terms
- Africa, Arteriovenous Shunt, Surgical, China, Developing Countries, Renal Dialysis, Humans, India, Kidney Failure, Chronic, United States, Global Health, Incidence, Prevalence, Survival Rate, Renal Replacement Therapy, Developed Countries, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
